Enterra Medical, Inc.

06/19/2026

When nausea and vomiting from gastroparesis won’t let up, it can feel like nothing helps. Enterra® Therapy offers another path — a reversible, customizable therapy that sends gentle electrical pulses to the stomach to help manage those tough nausea and vomiting symptoms from gastroparesis. Learn more about this unique therapy here: https://tinyurl.com/bdeuvsjn



Enterra Therapy requires surgery which has risks. Humanitarian Device.
Review Important Safety Information: https://tinyurl.com/j63nmz6h

05/29/2026

Today we recognize World Digestive Health Day—a global effort to raise awareness of digestive health and the importance of early evaluation. Too often, symptoms like chronic nausea and vomiting are dismissed or delayed in diagnosis. For people living with gastroparesis, that delay can mean prolonged uncertainty and unnecessary suffering.

At Enterra Medical, we support efforts to encourage earlier conversations, thorough evaluation, and greater awareness of digestive disorders so patients can move closer to answers and appropriate care.

If something doesn’t feel right, don’t wait. Talk to a healthcare provider and take the next step toward understanding your nausea and vomiting symptoms. Learn more at tinyurl.com/y8y9ywy9

World Gastroenterology Organisation

Humanitarian Device. Authorized by Federal law for use in the treatment of chronic intractable (drug refractory) nausea and vomiting secondary to gastroparesis of diabetic or idiopathic etiology in patients aged 18 to 70 years. The effectiveness of this device for this use has not been demonstrated. Rx Only. Review Important Safety Information: /tinyurl.com/sb9ny4e4
MKT-SM-04503, Rev A

05/22/2026

Better understanding gastroparesis can be an important step toward feeling more confident in your care journey.

Join us for an upcoming educational webinar designed for people living with gastroparesis and their caregivers. This session will provide information about the condition, treatment considerations, and questions you may want to discuss with your healthcare team.

Whether you are newly diagnosed or have been managing symptoms for some time, this webinar offers an opportunity to learn more and hear helpful insights in a supportive setting.

Reserve your spot today: https://tinyurl.com/yv9e4fb5

05/11/2026

This National Women’s Health Week, we’re joining the movement to advance women’s health through prevention, early detection, and meaningful innovation. Digestive health is a critical part of that effort yet for many women living with gastroparesis, chronic nausea and vomiting remain overlooked or misunderstood.

At Enterra Medical, we’re focused on advancing therapy options, raising awareness of digestive disorders, and elevating patient voices so more people get the care and outcomes they deserve.

If you or someone you know is living with nausea and vomiting symptoms of gastroparesis, learn more and talk to a healthcare provider about available options. Visit tinyurl.com/4jpspzuz

Office on Women's Health - U.S. Department of Health and Human Services

Humanitarian Device. Authorized by Federal law for use in the treatment of chronic intractable (drug refractory) nausea and vomiting secondary to gastroparesis of diabetic or idiopathic etiology in patients aged 18 to 70 years. The effectiveness of this device for this use has not been demonstrated. Rx Only. Review Important Safety Information: tinyurl.com/mauj7te5
MKT-SM-04503, Rev A

05/08/2026

May is Digestive Disease Month—a reminder that digestive disorders may be invisible, but their impact is not. For those living with gastroparesis, daily life can be unpredictable and challenging. At Enterra Medical, we’re committed to advancing therapy options that help patients better manage chronic nausea and vomiting and reclaim stability, confidence, and quality of life.

This month, we’re focused on raising awareness, amplifying patient voices, and continuing to push for progress in digestive health. Explore resources and learn more about gastroparesis at https://tinyurl.com/2jm869hc



Humanitarian Device. Authorized by Federal law for use in the treatment of chronic intractable (drug refractory) nausea and vomiting secondary to gastroparesis of diabetic or idiopathic etiology in patients aged 18 to 70 years. The effectiveness of this device for this use has not been demonstrated. Rx Only. Review Important Safety Information: https://tinyurl.com/44muv5wr
MKT-SM-04503, Rev A

03/06/2026

Living with gastroparesis can be challenging—but you’re not alone. Join us for a live virtual discussion to learn more about gastroparesis and available treatment options, including Enterra® Therapy for chronic nausea and vomiting. This educational session is designed for patients and caregivers who want to better understand the condition and hear helpful insights.

Friday, March 20
4:00–5:00 p.m. ET

Register to save your spot: https://tinyurl.com/mvpvjrvf

Humanitarian Device. Authorized by Federal law for use in the treatment of chronic intractable (drug refractory) nausea and vomiting secondary to gastroparesis of diabetic or idiopathic etiology in patients aged 18 to 70 years. The effectiveness of this device for this use has not been demonstrated. Rx Only. Review Important Safety Information: www.enterramedical.com/important-safety-information/

02/25/2026

Check out Emily's Enterra® Therapy story.

Individual results may vary. Enterra Therapy requires surgery which has risks. Humanitarian Device. www.enterramedical.com/important-safety-information

02/19/2026

Join the Association of Gastrointestinal Motility Disorders (AGMD)'s webinar next Tuesday, February 24 featuring Enterra Medical's VP & Medical Director, Dr. Kenneth Koch. Register today! agmdhope.aidaform.com/agmd-conversations-with-dr-kenneth-koch-gastroparesis-and-electrical-stimulation-therapy

Don't miss our upcoming program. Register today. https://agmdhope.aidaform.com/agmd-conversations-with-dr-kenneth-koch-gastroparesis-and-electrical-stimulation-therapy
, , ,

02/12/2026

Meet LiseAnne.
A registered nurse living with gastroparesis, she completed an accelerated nursing program more than 2,000 miles from home while relying on a J-tube for nutrition.
After years of managing TPN, central lines, and feeding tubes, Enterra Therapy has helped her live out loud again.

Today, she works full-time as a pediatric and adult float nurse and enjoys crafting, watching sports, visiting air and space museums, spending time with her dog, Simon, and rediscovering her love of food—especially baking sourdough. Learn more about Enterra® Therapy, an advanced treatment option for chronic, refractory nausea and vomiting due to gastroparesis. https://tinyurl.com/2yem7uu3


Feeding Tube Awareness Week® is a registered trademark of The Oley Foundation.

Humanitarian Device. Authorized by Federal law for use in the treatment of chronic intractable (drug refractory) nausea and vomiting secondary to gastroparesis of diabetic or idiopathic etiology in patients aged 18 to 70 years. The effectiveness of this device for this use has not been demonstrated. Rx Only. Review Important Safety Information: www.enterramedical.com/important-safety-information/
MKT-D-04221, Rev A

02/09/2026

Today marks the start of Feeding Tube Awareness Week®. This week, we honor the individuals who rely on feeding tubes, along with the caregivers, clinicians, and organizations who walk alongside them every day. At Enterra Medical, we stand with patients to raise awareness, reduce stigma, and foster understanding around enteral nutrition. For some people living with gastroparesis, enteral nutrition can be an important part of their care journey.

Learn more about advanced treatment options, including Enterra Therapy, and what next steps in care may look like:
https://tinyurl.com/3r9jrs5c


Feeding Tube Awareness Week® is a registered trademark of The Oley Foundation.

Humanitarian Device. Authorized by Federal law for use in the treatment of chronic intractable (drug refractory) nausea and vomiting secondary to gastroparesis of diabetic or idiopathic etiology in patients aged 18 to 70 years. The effectiveness of this device for this use has not been demonstrated. Rx Only. Review Important Safety Information: lnkd.in/eCr5zfhK
MKT-D-04221, Rev A